<DOC>
	<DOCNO>NCT01234922</DOCNO>
	<brief_summary>RATIONALE : Benazepril hydrochloride , lisinopril , ramipril , losartan potassium may help low blood pressure . PURPOSE : This phase II trial study well benazepril hydrochloride , lisinopril , ramipril , losartan potassium work treat hypertension patient solid tumor .</brief_summary>
	<brief_title>Benazepril Hydrochloride , Lisinopril , Ramipril , Losartan Potassium Treating Hypertension Patients With Solid Tumors</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine drug great effect Ang- ( 1-7 ) level cancer patient hypertension . SECONDARY OBJECTIVES : I . To determine effect drug level Ang II , VEGF , PlGF , ACE patient . OUTLINE : Patients randomize 1 4 treatment arm . - ARM I : Patients receive oral benazepril hydrochloride daily day 1-7 . - ARM II : Patients receive oral lisinopril daily day 1-7 . - ARM III : Patients receive oral ramipril twice daily day 1-7 . - ARM IV : Patients receive oral losartan potassium daily day 1-7 . In arm , treatment continue absence unacceptable toxicity .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Patients must histologically cytologically confirm solid tumor malignancy AND hypertension , define systolic pressure &gt; 130 OR diastolic pressure &gt; 80 Patients active chemotherapy radiation therapy ; start treatment ACEI ARB must occur least four week last dose chemotherapy radiation therapy Creatinine &lt; 2.5 Potassium &lt; ULN Ability understand willingness sign write informed consent document HIV positive patient eligible participate study Patients pregnant nursing due significant risk fetus/infant Patients unable take oral medication Patients currently take ACEInhibitor ARB</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>